Diabetes, Nutrition Disorders, Obesity, Overweight, Metabolic Syndrome x, Body Weight, Glucose Metabolism Disorders, Metabolic Diseases
Conditions
Keywords
Nutritional support, Diet therapy, Diabetes prevention, Insoluble fiber, Healthy life style, Weight loss
Brief summary
High intake of insoluble fiber is strongly associated with a reduced incidence of diabetes and cardiovascular events in prospective observation studies. Our primary objective is to compare a life style diabetes prevention program(PRAEDIAS) with and without added insoluble fibers in its effectiveness to prevent incident diabetes type 2 in high risk individuals with impaired glucose tolerance. Subjects with IGT not willing to participate in the intervention will be used as independent controls. Secondary aims are to identify mechanisms of action with regard to body composition, anti-inflammatory and metabolic effects of fibers. We propose a randomized, prospective intervention study. The results will be of general relevance for guidance of fiber intake in the population and will help the food industry to design healthy high fiber foods. Fiber can be added at low cost to numerous foods. Increased fiber intake may therefore provide a simple non-cognitive prevention strategy effective at the population level.
Detailed description
The overall objective is to investigate whether insoluble fibers added to standard nutrition can reduce the progression of impairment of glucose metabolism in a high risk population with impaired glucose metabolism. Large prospective cohort studies clearly show that mainly insoluble cereal fiber from whole grains is associated with reduced risk of type 2 diabetes and cardiovascular disease. However, there is a lack of evidence from prospective intervention studies targeted to evaluate the potential of dietary fibers to reduce diabetes and cardiovascular disease as recently stated by the Cochrane Foundation. Dietary fiber intake is generally much lower than currently recommended, which may in part be related to side effects of whole grain nutrients and their gustatory properties. Intestinally uncomfortable effects are at least partly related to fermentation which is much less induced by insoluble non-fermentable fibers than by soluble fermentable fibers. The prospective demonstration of beneficial effects of insoluble fibers in preventing diabetes type 2 will allow detailed nutritional recommendations. This may serve to support the consumption of metabolically beneficial constituents of fiber-rich diets and help to increase fiber intake by high fiber natural nutrients or everyday nutrients enriched in insoluble natural fibers.
Interventions
200ml drinks enriched with 7,5g of fiber (90% insoluble fiber, 10% soluble fiber), BID, over 24 months
200ml Placebo, BID, over 24 months
Sponsors
Study design
Eligibility
Inclusion criteria
* Impaired glucose tolerance * Age\>18years old * both gender
Exclusion criteria
* Diabetes type 1 and type 2 * chronic or malignant disease * Intake of metabolic influence drugs * Food allergies, fiber intolerance
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of 2h-postprandial blood glucose from IGT to diabetes mellitus type 2 or normal glucose tolerance (NGT) | 0, 12, 24 months | Change of the glucose metabolism (OGTT) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change of insulin secretion | 0, 12, 24 months | Measurement by the OGTT |
| Expression of inflammatory markers in blood | 0, 6, 12, 18, 24 months | CRP, leukocytes, adipocytokines |
| Biometric data | 0, 6, 12, 18, 24 months | Nutritional impact of blood pressure, anthropometry (body weight and body composition) |
| Change of insulin sensitivity | 0, 12, 24 months | Measurement by HOMA and OGIS from the OGTT |
| Development of indices for the prediction of fat mass | 0, 12, 24 months | Change of fat fraction in liver, abdominal and in the total body fat measuring by MRI/H1-spectroscopy |
| Determination of gene expression in adipose tissue | 0, 12, 24 month | Determination of inflammatory and other transcripts in sc adipose tissue in a fat biopsy. |
| Assessment of cognitive performance | 0, 12, 24 months | — |
Countries
Germany